The invention discloses a chordoma
cell line and application thereof and belongs to the field of oncobiology. The preservation number of a human chordoma
cell line (BHC2) is CGMCC (China General
Microbiological Culture Collection Center) NO: 5321. The
cell line is obtained by separating culture in a chordoma tissue
cut from a basicranial chordoma patient operation and is subjected to
in vitro subculture for over 14 passages. The cell has the biological characteristics of a notochord-derived cell that the cells are physaliphores arrayed in a cord shape under an
optical microscope and a large amount of cavity structures exist in
cytoplasm under the transmission of an
electron microscope; and the cells expresses various marker proteins of the notochord-derived cell, namely Brachyury, S100,
Galectin-3 and Fascin-1. The cell has the tumor characteristic that
chromosome is of a heteroploid
karyotype; the percentages at each phase of a
cell cycle are as follows: 51.3 percent at G1 phase, 23.6 percent at S phase, 25 percent at G2-M phase and the ratio of the G2 to the G1 is approximate to 2, and thus the cell proliferation feature of
tumor cells is shown; and the cells obtain tumorigenesis ability after being injected into a
nude mouse body. The chordoma cell line can be cultured
in vitro for a long term and keeps the cell stability unchanged and is a powerful tool for researching a targeted chordoma tumor medicament.